Thrombelastogram or Thrombelastography (TEG) has been in used as point of care test in the management of hemorrhagic shock and to monitor patients during surgeries. With the help of Viscoelastic test (Thromelastography / Rotational thrombelastometry) the protocol based massive transfusion has been evolving into patient based individualized massive transfusion. However, the evidence on the utility of TEG in diagnosing fibrinolysis activity is very limited in international level. To take it further, TEG can be utilized in identifying and categorizing it into primary or secondary fibrinolysis based on the manufacture’s protocol. The pathophysiology and hence the management of primary fibrinolysis is entirely different from secondary fibrinolysis as seen in trauma and sepsis. Even though there are various standardized tests to monitor the enzymatic coagulation part of the hemostasis, like PT and aPTT, the investigations to diagnose fibrinolysis activity are not so well developed compared to others. Diagnosing fibrinolysis and categorizing them into primary and secondary is gaining international attention because of the renewed classification of some of the coagulopathies based on fibrinolysis activity and type.